Nuvation Bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nuvation Bio Stock Summary

Nuvation Bio competes with Assembly Biosciences, Instil Bio, Achilles Therapeutics, NextCure, and CytomX Therapeutics. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people.

Nuvation Bio Key Financial Ratios

Nuvation Bio Key Balance Sheet Accounts

Nuvation Bio Key Cash Accounts

Nuvation Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nuvation Bio's current stock value. Our valuation model uses many indicators to compare Nuvation Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nuvation Bio competition to find correlations between indicators driving Nuvation Bio's intrinsic value. More Info.Nuvation Bio is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . At present, Nuvation Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nuvation Bio's earnings, one of the primary drivers of an investment's value.

Nuvation Bio Systematic Risk

Today, most investors in Nuvation Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nuvation Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nuvation Bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nuvation Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nuvation Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nuvation Bio based on widely used predictive technical indicators. In general, we focus on analyzing Nuvation Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nuvation Bio's daily price indicators and compare them against related drivers.

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.